1. Home
  2. DNN vs TRVI Comparison

DNN vs TRVI Comparison

Compare DNN & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

N/A

Current Price

$2.21

Market Cap

2.3B

ML Signal

N/A

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

N/A

Current Price

$13.65

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DNN
TRVI
Founded
1954
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
DNN
TRVI
Price
$2.21
$13.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$4.73
★ $28.18
AVG Volume (30 Days)
★ 26.8M
2.6M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.91
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$321.58
N/A
Revenue Next Year
$38.26
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$9.82
52 Week High
$4.43
$20.22

Technical Indicators

Market Signals
Indicator
DNN
TRVI
Relative Strength Index (RSI) 36.99 49.73
Support Level $2.10 $13.08
Resistance Level $3.43 $13.55
Average True Range (ATR) 0.12 0.60
MACD 0.03 0.27
Stochastic Oscillator 23.44 76.06

Price Performance

Historical Comparison
DNN
TRVI

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is engaged in uranium mining-related activities, including the acquisition, exploration, development, and mining of uranium-bearing properties, as well as the processing, sale, and investment in uranium. The company's key properties include Wheeler River, Waterbury Lake, McClean Lake, Midwest, and others. It operates through two segments: the Mining segment and the Corporate and Other segment. The majority of the company's revenue is generated from the Mining segment, which includes activities related to exploration, evaluation, and development, mining, milling (including toll milling), and the sale of mineral concentrates.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: